Constellation Pharmaceuticals, Inc. (CNST) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
215 FIRST STREET CAMBRIDGE, MA 02142 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | 3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 421,448 | 489,354 | 520,513 | 358,849 | 383,934 | 89,066 | |||
| Cash and cash equivalents | 163,693 | 116,996 | 179,112 | 190,464 | 334,332 | 78,977 | |||
| Short-term investments | 257,755 | 372,358 | 341,401 | 168,385 | 49,602 | 10,089 | |||
| Other undisclosed current assets | 7,161 | 5,112 | 2,586 | 2,817 | 3,055 | 3,144 | |||
| Total current assets: | 428,609 | 494,466 | 523,099 | 361,666 | 386,989 | 92,210 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 3,541 | 8,710 | 9,378 | 10,103 | 10,745 | 11,372 | |||
| Property, plant and equipment | 1,497 | 1,395 | 1,443 | 867 | 971 | 1,149 | |||
| Restricted cash and investments | 3,233 | 425 | 425 | 425 | 425 | 425 | |||
| Deferred costs | 61 | ||||||||
| Other undisclosed noncurrent assets | 4,974 | 453 | 453 | ||||||
| Total noncurrent assets: | 13,245 | 10,983 | 11,699 | 11,395 | 12,141 | 13,007 | |||
| TOTAL ASSETS: | 441,854 | 505,449 | 534,798 | 373,061 | 399,130 | 105,217 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 15,865 | 9,920 | 8,952 | 5,489 | 11,989 | 8,030 | |||
| Employee-related liabilities | 5,545 | 4,153 | 2,868 | 1,636 | 4,527 | 2,782 | |||
| Accounts payable | 9,853 | 5,371 | 5,659 | 3,558 | 7,278 | 4,983 | |||
| Accrued liabilities | 467 | 396 | 425 | 295 | 184 | 265 | |||
| Debt | 5,670 | 2,150 | 2,747 | 2,562 | 2,382 | ||||
| Other liabilities | 341 | 420 | 529 | 423 | 497 | 414 | |||
| Other undisclosed current liabilities | 14,342 | 15,264 | 15,653 | 10,626 | 7,707 | 6,928 | |||
| Total current liabilities: | 30,548 | 31,274 | 27,284 | 19,285 | 22,755 | 17,754 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 582 | 30,526 | 34,817 | 37,697 | 38,401 | 39,084 | |||
| Long-term debt, excluding current maturities | 24,088 | 27,569 | 29,681 | 29,642 | 29,603 | ||||
| Liabilities, other than long-term debt | 879 | 716 | 553 | 390 | 227 | ||||
| Other liabilities | 879 | 716 | 553 | 390 | 227 | ||||
| Operating lease, liability | 582 | 6,438 | 7,248 | 8,016 | 8,759 | 9,481 | |||
| Other undisclosed noncurrent liabilities | (582) | ||||||||
| Total noncurrent liabilities: | 31,405 | 35,533 | 38,250 | 38,791 | 39,311 | ||||
| Total liabilities: | 31,130 | 62,679 | 62,817 | 57,535 | 61,546 | 57,065 | |||
| Equity | |||||||||
| Equity, attributable to parent | 410,724 | 442,770 | 471,981 | 315,526 | 337,584 | 48,152 | |||
| Common stock | 5 | 5 | 5 | 4 | 4 | 3 | |||
| Additional paid in capital | 856,460 | 850,991 | 846,305 | 660,443 | 656,973 | 343,327 | |||
| Accumulated other comprehensive income (loss) | 3 | 134 | 255 | (90) | (6) | 1 | |||
| Accumulated deficit | (445,744) | (408,360) | (374,584) | (344,831) | (319,387) | (295,179) | |||
| Total equity: | 410,724 | 442,770 | 471,981 | 315,526 | 337,584 | 48,152 | |||
| TOTAL LIABILITIES AND EQUITY: | 441,854 | 505,449 | 534,798 | 373,061 | 399,130 | 105,217 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | 3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 220 | 94 | ||||||
| Sublease income | 94 | |||||||
| Gross profit: | 94 | |||||||
| Operating expenses | (35,899) | (33,378) | (29,587) | (25,983) | (24,057) | (21,051) | ||
| Other undisclosed operating loss | (94) | |||||||
| Operating loss: | (35,899) | (33,378) | (29,587) | (25,983) | (24,057) | (21,051) | ||
| Nonoperating income (expense) | (1,485) | (398) | (142) | 554 | (127) | (98) | ||
| Investment income, nonoperating | 302 | 459 | 686 | 1,404 | 730 | 507 | ||
| Interest and debt expense | 1,063 | (857) | (857) | (850) | (857) | (605) | ||
| Loss from continuing operations before equity method investments, income taxes: | (36,321) | (34,633) | (30,586) | (26,279) | (25,041) | (21,754) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (1,063) | 857 | 857 | 850 | 2,115 | |||
| Loss from continuing operations before income taxes: | (37,384) | (33,776) | (29,729) | (25,429) | (22,926) | (21,754) | ||
| Income tax expense | (24) | (15) | ||||||
| Other undisclosed loss from continuing operations | (24) | |||||||
| Loss from continuing operations: | (37,384) | (33,776) | (29,753) | (25,444) | (22,950) | (21,754) | ||
| Loss before gain (loss) on sale of properties: | (37,384) | (33,776) | (29,753) | (25,444) | (22,950) | (21,754) | ||
| Other undisclosed net loss | (1,258) | |||||||
| Net loss: | (37,384) | (33,776) | (29,753) | (25,444) | (24,208) | (21,754) | ||
| Other undisclosed net income attributable to parent | 605 | |||||||
| Net loss attributable to parent: | (37,384) | (33,776) | (29,753) | (25,444) | (24,208) | (21,149) | ||
| Other undisclosed net loss available to common stockholders, basic | (6) | |||||||
| Net loss available to common stockholders, diluted: | (37,384) | (33,776) | (29,753) | (25,444) | (24,214) | (21,149) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | 3/31/2020 Q1 | 12/31/2019 Q4 | 9/30/2019 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (37,384) | (33,776) | (29,753) | (25,444) | (24,208) | (21,754) | ||
| Comprehensive loss: | (37,384) | (33,776) | (29,753) | (25,444) | (24,208) | (21,754) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (131) | (121) | 345 | (84) | (1) | 595 | ||
| Comprehensive loss, net of tax, attributable to parent: | (37,515) | (33,897) | (29,408) | (25,528) | (24,209) | (21,159) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.